Joshua Dennerlein
Stock Analyst at B of A Securities
(1.69)
# 3,301
Out of 5,182 analysts
91
Total ratings
40.32%
Success rate
-3.4%
Average return
Main Sectors:
Stocks Rated by Joshua Dennerlein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OHI Omega Healthcare Investors | Downgrades: Underperform | $52 → $46 | $45.53 | +1.03% | 12 | Apr 14, 2026 | |
| TRI Thomson Reuters | Maintains: Neutral | $100 → $115 | $87.98 | +30.71% | 2 | Mar 10, 2026 | |
| CPT Camden Property Trust | Maintains: Buy | $142 → $137 | $101.78 | +34.60% | 5 | Nov 12, 2025 | |
| LINE Lineage | Downgrades: Underperform | $47 → $42 | $35.89 | +17.02% | 2 | Aug 11, 2025 | |
| NTST NETSTREIT | Upgrades: Neutral | $18 → $19 | $20.00 | -5.00% | 3 | Jul 28, 2025 | |
| FVR FrontView REIT | Downgrades: Underperform | $15 → $11 | $17.06 | -35.52% | 2 | Jun 17, 2025 | |
| SUI Sun Communities | Maintains: Underperform | $124 → $132 | $130.05 | +1.50% | 3 | May 12, 2025 | |
| CTAS Cintas | Reinstates: Buy | $250 | $176.14 | +41.93% | 1 | Apr 10, 2025 | |
| MSCI MSCI Inc. | Initiates: Neutral | $585 | $545.69 | +7.20% | 1 | Apr 10, 2025 | |
| VRSK Verisk Analytics | Reinstates: Underperform | $280 | $170.63 | +64.10% | 1 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $221 → $242 | $210.99 | +14.70% | 7 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $31 → $34 | $33.70 | +0.89% | 3 | Oct 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $31 | $48.82 | -36.50% | 2 | Sep 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $92 | $84.94 | +8.31% | 1 | Sep 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $307 → $321 | $251.42 | +27.67% | 3 | Sep 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $144 → $189 | $126.34 | +49.60% | 3 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $45 → $40 | $56.08 | -28.67% | 4 | May 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $18 → $25 | $16.87 | +48.19% | 2 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $48 → $53 | $85.34 | -37.90% | 9 | Jan 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $18 → $6 | $10.90 | -44.95% | 1 | Nov 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $42 → $33 | $35.12 | -6.04% | 1 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $52 | $63.81 | -18.51% | 1 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $20.34 | - | 4 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $67 → $54 | $71.61 | -24.59% | 4 | Sep 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $27 | $20.94 | +28.94% | 1 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $28 → $34 | $12.35 | +171.26% | 5 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $32.30 | - | 4 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $76 → $78 | $77.80 | +0.26% | 2 | Jun 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $52 → $47 | $44.08 | +6.62% | 2 | Jan 20, 2022 |
Omega Healthcare Investors
Apr 14, 2026
Downgrades: Underperform
Price Target: $52 → $46
Current: $45.53
Upside: +1.03%
Thomson Reuters
Mar 10, 2026
Maintains: Neutral
Price Target: $100 → $115
Current: $87.98
Upside: +30.71%
Camden Property Trust
Nov 12, 2025
Maintains: Buy
Price Target: $142 → $137
Current: $101.78
Upside: +34.60%
Lineage
Aug 11, 2025
Downgrades: Underperform
Price Target: $47 → $42
Current: $35.89
Upside: +17.02%
NETSTREIT
Jul 28, 2025
Upgrades: Neutral
Price Target: $18 → $19
Current: $20.00
Upside: -5.00%
FrontView REIT
Jun 17, 2025
Downgrades: Underperform
Price Target: $15 → $11
Current: $17.06
Upside: -35.52%
Sun Communities
May 12, 2025
Maintains: Underperform
Price Target: $124 → $132
Current: $130.05
Upside: +1.50%
Cintas
Apr 10, 2025
Reinstates: Buy
Price Target: $250
Current: $176.14
Upside: +41.93%
MSCI Inc.
Apr 10, 2025
Initiates: Neutral
Price Target: $585
Current: $545.69
Upside: +7.20%
Verisk Analytics
Apr 10, 2025
Reinstates: Underperform
Price Target: $280
Current: $170.63
Upside: +64.10%
Feb 18, 2025
Maintains: Buy
Price Target: $221 → $242
Current: $210.99
Upside: +14.70%
Oct 21, 2024
Upgrades: Buy
Price Target: $31 → $34
Current: $33.70
Upside: +0.89%
Sep 24, 2024
Maintains: Buy
Price Target: $27 → $31
Current: $48.82
Upside: -36.50%
Sep 24, 2024
Initiates: Buy
Price Target: $92
Current: $84.94
Upside: +8.31%
Sep 24, 2024
Downgrades: Neutral
Price Target: $307 → $321
Current: $251.42
Upside: +27.67%
Aug 12, 2024
Upgrades: Buy
Price Target: $144 → $189
Current: $126.34
Upside: +49.60%
May 20, 2024
Downgrades: Underperform
Price Target: $45 → $40
Current: $56.08
Upside: -28.67%
Apr 1, 2024
Upgrades: Buy
Price Target: $18 → $25
Current: $16.87
Upside: +48.19%
Jan 16, 2024
Upgrades: Buy
Price Target: $48 → $53
Current: $85.34
Upside: -37.90%
Nov 7, 2023
Downgrades: Underperform
Price Target: $18 → $6
Current: $10.90
Upside: -44.95%
Oct 31, 2023
Downgrades: Neutral
Price Target: $42 → $33
Current: $35.12
Upside: -6.04%
Oct 10, 2023
Downgrades: Neutral
Price Target: $52
Current: $63.81
Upside: -18.51%
Oct 10, 2023
Upgrades: Buy
Price Target: n/a
Current: $20.34
Upside: -
Sep 26, 2023
Maintains: Underperform
Price Target: $67 → $54
Current: $71.61
Upside: -24.59%
Jun 13, 2023
Initiates: Underperform
Price Target: $27
Current: $20.94
Upside: +28.94%
Nov 14, 2022
Upgrades: Buy
Price Target: $28 → $34
Current: $12.35
Upside: +171.26%
Aug 24, 2022
Upgrades: Buy
Price Target: n/a
Current: $32.30
Upside: -
Jun 2, 2022
Upgrades: Buy
Price Target: $76 → $78
Current: $77.80
Upside: +0.26%
Jan 20, 2022
Downgrades: Underperform
Price Target: $52 → $47
Current: $44.08
Upside: +6.62%